Caseware UK (AP4) 2024.0.164 2024.0.164 2025-02-282025-02-28truetruefalse2024-03-012016truefalsefalse 02759485 2024-03-01 2025-02-28 02759485 2023-03-01 2024-02-29 02759485 2025-02-28 02759485 2024-02-29 02759485 1 2024-03-01 2025-02-28 02759485 1 2023-03-01 2024-02-29 02759485 d:CompanySecretary1 2024-03-01 2025-02-28 02759485 d:Director1 2024-03-01 2025-02-28 02759485 d:Director2 2024-03-01 2025-02-28 02759485 d:Director3 2024-03-01 2025-02-28 02759485 d:RegisteredOffice 2024-03-01 2025-02-28 02759485 e:Buildings e:LongLeaseholdAssets 2024-03-01 2025-02-28 02759485 e:Buildings e:LongLeaseholdAssets 2025-02-28 02759485 e:Buildings e:LongLeaseholdAssets 2024-02-29 02759485 e:Buildings e:ShortLeaseholdAssets 2024-03-01 2025-02-28 02759485 e:LandBuildings 2025-02-28 02759485 e:LandBuildings 2024-02-29 02759485 e:MotorVehicles 2024-03-01 2025-02-28 02759485 e:MotorVehicles 2025-02-28 02759485 e:MotorVehicles 2024-02-29 02759485 e:MotorVehicles e:OwnedOrFreeholdAssets 2024-03-01 2025-02-28 02759485 e:FurnitureFittings 2024-03-01 2025-02-28 02759485 e:FurnitureFittings 2025-02-28 02759485 e:FurnitureFittings 2024-02-29 02759485 e:FurnitureFittings e:OwnedOrFreeholdAssets 2024-03-01 2025-02-28 02759485 e:OwnedOrFreeholdAssets 2024-03-01 2025-02-28 02759485 e:CurrentFinancialInstruments 2025-02-28 02759485 e:CurrentFinancialInstruments 2024-02-29 02759485 e:Non-currentFinancialInstruments 2025-02-28 02759485 e:Non-currentFinancialInstruments 2024-02-29 02759485 e:CurrentFinancialInstruments e:WithinOneYear 2025-02-28 02759485 e:CurrentFinancialInstruments e:WithinOneYear 2024-02-29 02759485 e:Non-currentFinancialInstruments e:AfterOneYear 2025-02-28 02759485 e:Non-currentFinancialInstruments e:AfterOneYear 2024-02-29 02759485 f:UnitedKingdom 2024-03-01 2025-02-28 02759485 f:UnitedKingdom 2023-03-01 2024-02-29 02759485 f:RestEuropeOutsideUK 2024-03-01 2025-02-28 02759485 f:RestEuropeOutsideUK 2023-03-01 2024-02-29 02759485 e:UKTax 2024-03-01 2025-02-28 02759485 e:UKTax 2023-03-01 2024-02-29 02759485 e:ShareCapital 2025-02-28 02759485 e:ShareCapital 2024-02-29 02759485 e:RetainedEarningsAccumulatedLosses 2024-03-01 2025-02-28 02759485 e:RetainedEarningsAccumulatedLosses 2025-02-28 02759485 e:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 02759485 e:RetainedEarningsAccumulatedLosses 2024-02-29 02759485 e:RetainedEarningsAccumulatedLosses 2023-03-01 02759485 e:AcceleratedTaxDepreciationDeferredTax 2025-02-28 02759485 e:AcceleratedTaxDepreciationDeferredTax 2024-02-29 02759485 e:OtherDeferredTax 2025-02-28 02759485 e:OtherDeferredTax 2024-02-29 02759485 d:OrdinaryShareClass1 2024-03-01 2025-02-28 02759485 d:OrdinaryShareClass1 2025-02-28 02759485 d:OrdinaryShareClass1 2024-02-29 02759485 d:FRS102 2024-03-01 2025-02-28 02759485 d:Audited 2024-03-01 2025-02-28 02759485 d:FullAccounts 2024-03-01 2025-02-28 02759485 d:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 02759485 e:WithinOneYear 2025-02-28 02759485 e:WithinOneYear 2024-02-29 02759485 e:BetweenOneFiveYears 2025-02-28 02759485 e:BetweenOneFiveYears 2024-02-29 02759485 2 2024-03-01 2025-02-28 02759485 g:PoundSterling 2024-03-01 2025-02-28 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 02759485









ET BROWNE (UK) LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2025

 
ET BROWNE (UK) LIMITED
 
 
COMPANY INFORMATION


Directors
A H Neis 
R C Neis 
P R R Johns 




Company secretary
A H Neis



Registered number
02759485



Registered office
35 Ballards Lane

London

N3 1XW




Independent auditors
BKL Audit LLP
Chartered Accountants & Statutory Auditor

35 Ballards Lane

London

N3 1XW





 
ET BROWNE (UK) LIMITED
 

CONTENTS



Page
Strategic Report
 
 
1 - 2
Directors' Report
 
 
3 - 4
Independent Auditors' Report
 
 
5 - 8
Statement of Income and Retained Earnings
 
 
9
Statement of Financial Position
 
 
10
Notes to the Financial Statements
 
 
11 - 23


 
ET BROWNE (UK) LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2025

Introduction
 
The following is review of the Company’s performance in the financial year ended 28th February 2025, during which it successfully managed to control the chief risks to its business, while at the same time managing to consolidate its position in the marketplace once again; and creating a platform from which it can approach future trading from a position of some strength. 

Business review
 
While some of the variable risk factors that influenced previous performance were significantly lessened during the period under review, the Company still had to contend with rising production costs and some early adversity in the financial markets.
Despite this, the Company’s products managed to outperform management expectations for much of the review period and to achieve a second successive year of sales growth, after the preceding, covid-affected, years of either stagnant or negative performance.
The past two years have mainly been about rebuilding business lost through supply-chain issues during the pandemic period, as well as rebuilding our balance sheet that had been affected by costs associated with those issues and the negative margin effect of foreign exchange transactions.
As might be expected, the amount of R&D conducted, resulting in new product development; was significantly curtailed during the same period. So, although we have been able to introduce some small additions to our product portfolio over the last year, the lack of any major range additions meant that all our A&P spend was directed at protecting our brand and maintaining the existing status of our products in the market. 
This approach seems to have been justified by our financial results and with a range of new, high-value lines, being launched now; we approach the new financial year with a degree of confidence.

Principal risks and uncertainties
 
Currency and logistics risk
With almost all production and logistical costs denominated in U.S. Dollars and a Trans-Atlantic supply chain, the principal risks to our business are quite obvious – major fluctuations in Dollar/Sterling exchange rates and logistical issues that might affect our inventory replenishment. However, the Company has faced these challenges for over thirty years and has developed strategies to deal with the main day-to-day effects that may occur. In relation to currency transactions, we calculate our costs on a prudent basis and then conduct FX purchases that match or better those calculations. With logistics, we are constantly reviewing the performance of different carriers in order to achieve the best value in terms of cost and time.
While this approach has sustained the Company through many years of trading, it is difficult to anticipate major events that may affect those variables. In the past few years, we have had to cope with disruption to our supply-chain and increasing costs associated with the pandemic. We have also had to contend with unexpectedly large variations in exchange rates, such as the large-scale devaluation of Sterling during the previous UK Government’s change of leadership. During one recent financial year, we experienced adverse effects from both directions, resulting in a significant loss during the trading period. However, with changed circumstances we have subsequently been able to recover those negative effects. The fact that we have been able to achieve this, while subsequently improving our revenues gives confidence for trading in the future.

Page 1

 
ET BROWNE (UK) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025

Financial key performance indicators
 
Given the principal risks already outlined, it should be clear that the main performance indicators for the Company are:
• Its ability to maintain, and grow, the levels of our sales revenues.
• That it should show a positive operating margin result in the financial period.
Aside from the risks mentioned, the Company operates in a highly competitive marketplace, with rival brands and products that are often able to outperform it in terms of A&P expenditure. The fact that we have achieved significant growth over a period of time, despite all those pressures suggests that our business model has been generally sound.

Other key performance indicators
 
Aside from all the commercial factors already covered, the Company also operates in a highly regulated market which has consumer safety at its core. It is therefore necessary for the company to comply with increasingly complex product oversight as well as increasing packaging and sustainability elements. The result of any non-compliance could have a major impact on the Company’s brand image and sales. The fact that we have never been subject to any such issue is the result of a constant awareness of the requirements being imposed, allied with a continuous review of all associated production effects.


This report was approved by the board and signed on its behalf.



P R R Johns
Director

Date: 25 June 2025

Page 2

 
ET BROWNE (UK) LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2025

The directors present their report and the audited financial statements for the year ended 28 February 2025.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the audited financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare audited financial statements for each financial year. Under that law the directors have elected to prepare the audited financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the audited financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these audited financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the audited financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the audited financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Principal activity

The principal activity of the Company throughout the year continued to be the marketing and selling of cosmetic
products.

Results and dividends

The profit for the year, after taxation, amounted to £847,626 (2024 - £984,231).

There were no dividends declared in the current or prior year.

Directors

The directors who served during the year were:

A H Neis 
R C Neis 
P R R Johns 

Future developments

The Company will continue to develop new products to maintain its current place in the market.

Page 3

 
ET BROWNE (UK) LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

There have been no significant events affecting the Company since the year end.

Auditors

Under section 487(2) of the Companies Act 2006BKL Audit LLP will be deemed to have been reappointed as auditors 28 days after these financial statements were sent to members or 28 days after the latest date prescribed for filing the accounts with the registrar, whichever is earlier.

This report was approved by the board on 25 June 2025 and signed on its behalf.
 





P R R Johns
Director

Page 4

 
ET BROWNE (UK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF ET BROWNE (UK) LIMITED
 

Opinion


We have audited the financial statements of ET Browne (UK) Limited (the 'Company') for the year ended 28 February 2025, which comprise the Statement of Income and Retained Earnings, the Statement of Financial Position and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 28 February 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 5

 
ET BROWNE (UK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF ET BROWNE (UK) LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
ET BROWNE (UK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF ET BROWNE (UK) LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Enquiring of management around actual and potential litigation and claims;
Reviewing minutes of meetings of those charged with governance;
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
Performing audit work over the risks of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:


Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion of the effectiveness of the Company's internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our Auditors' Report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our Auditors' Report. However, future events or conditions may cause the Company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Page 7

 
ET BROWNE (UK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF ET BROWNE (UK) LIMITED (CONTINUED)



We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Myfanwy Neville FCA (Senior Statutory Auditor)
  
for and on behalf of
BKL Audit LLP
 
Chartered Accountants
Statutory Auditor
  
London

26 June 2025
Page 8

 
ET BROWNE (UK) LIMITED
 
 
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2025
2024
Note
£
£

  

Turnover
 4 
27,899,940
26,440,978

Cost of sales
  
(20,200,400)
(19,424,867)

Gross profit
  
7,699,540
7,016,111

Administration expenses
  
(1,475,101)
(1,514,388)

Distribution costs
  
(5,178,309)
(4,311,953)

Other operating income
 5 
(43,009)
(113,265)

Operating profit
  
1,089,139
1,303,035

Interest receivable and similar income
  
25,487
13,622

Profit before tax
  
1,114,626
1,316,657

Tax on profit
 10 
(267,000)
(332,426)

Profit after tax
  
847,626
984,231

  

  

Retained earnings at the beginning of the year
  
989,741
5,510

  
989,741
5,510

Profit for the year
  
847,626
984,231

Retained earnings at the end of the year
  
1,837,367
989,741
The notes on pages 11 to 23 form part of these financial statements.

Page 9

 
ET BROWNE (UK) LIMITED
REGISTERED NUMBER: 02759485

STATEMENT OF FINANCIAL POSITION
AS AT 28 FEBRUARY 2025

28 February
29 February
2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 11 
71,589
62,035

  
71,589
62,035

Current assets
  

Stocks
  
-
1,912

Debtors: amounts falling due within one year
 12 
3,723,186
3,719,754

Cash at bank and in hand
  
1,913,122
700,298

  
5,636,308
4,421,964

Creditors: amounts falling due within one year
 13 
(3,831,974)
(3,459,721)

Net current assets
  
 
 
1,804,334
 
 
962,243

Total assets less current liabilities
  
1,875,923
1,024,278

Creditors: amounts falling due after more than one year
 14 
(15,269)
(11,250)

Provisions for liabilities
  

Deferred tax
 15 
(13,287)
(13,287)

  
 
 
(13,287)
 
 
(13,287)

Net assets
  
1,847,367
999,741


Capital and reserves
  

Called up share capital 
 16 
10,000
10,000

Profit and loss account
  
1,837,367
989,741

  
1,847,367
999,741


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



R C Neis
P R R Johns
Director
Director


Date: 25 June 2025
Date:25 June 2025

The notes on pages 11 to 23 form part of these financial statements.

Page 10

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

1.


General information

The Company is a private Company limited by shares and is incorporated in England and Wales.
The principal activity of the Company is the marketing and selling of cosmetic products.
The address of its Registered Office is 35 Ballards Lane, London N3 1XW.
The principal place of business is Unit 5, Loughton Business Centre, 5 Langston Rd, Loughton, Essex IG10 3FL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of ET Browne Drug Co. Inc. as at 28 February 2025 and these financial statements may be obtained from 440 Sylvan Ave Ste 100, Englewood Cliffs, NJ 07632.

 
2.3

Going concern

The directors have reviewed current trading, along with those forecasts, and have concluded that the business has sufficient funds to trade for the foreseeable future.
Therefore, the Company’s financial statements have been prepared on a going concern basis, which assumes that the Company will continue to trade for the foreseeable future – being a period of at least twelve months from the date of approval of these financial statements and will be able to meet its debts as they fall due.

Page 11

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Turnover comprises revenue recognised by the Company in respect of goods supplied, exclusive of Value Added Tax and trade discounts. 
Revenue is recognised on delivery of goods.

 
2.6

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to the Statement of Income and Retained Earnings on a straight-line basis over the lease term.

 
2.7

Interest income

Interest income is recognised in the Statement of Income and Retained Earnings using the effective interest method.

Page 12

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Statement of Income and Retained Earnings when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


Page 13

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2.Accounting policies (continued)

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when that cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to the Statement of Income and Retained Earnings during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Short-term leasehold property
-
10%
Straight line
Motor vehicles
-
10%
Straight line
Fixtures and fittings
-
33%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Financial instruments

The Company enters into basic financial instrument transactions, that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans from related parties.
(i) Financial assets
Basic financial assets, including trade and other debtors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
 
Page 14

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2.Accounting policies (continued)


2.12
Financial instruments (continued)

Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in Statement of Income and Retained Earnings.
If there is decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in the Statement of Income and Retained Earnings.
Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.
(ii) Financial liabilities
Basic financial liabilities, including trade, amounts owed to group companies, other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.
(iii) Offsetting
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
 
Page 15

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

2.Accounting policies (continued)


2.12
Financial instruments (continued)

(iii) Non-basic financial instruments
The Company also enters into non-basic financial instruments transactions such as forward foreign exchange contracts.
Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in the statement of comprehensive income in administrative expenses. The Company does not currently apply hedge accounting for interest rate and foreign exchange derivatives.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the Statement of Financial Position date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates.
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
i) Useful economic lives of tangible assets:
The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are reassessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See the tangible fixed asset for the carrying amount of the plant and machinery, and accounting policy note 2.9 for the useful economic lives for each class of assets.


4.


Turnover

The whole of the turnover is attributable to sale of cosmetic products.

Analysis of turnover by country of destination:

2025
2024
£
£

United Kingdom
24,878,686
23,948,007

Rest of Europe
3,021,254
2,492,971

27,899,940
26,440,978


Page 16

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

5.


Other operating income

2025
2024
£
£

Other operating income
-
64,389

Rents receivable
43,009
48,876

43,009
113,265



6.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Exchange differences
(544,580)
(846,880)

Other operating lease rentals
120,114
113,844


7.


Auditors' remuneration

During the year, the Company obtained the following services from the Company's auditors:


2025
2024
£
£

Fees payable to the Company's auditors for the audit of the Company's financial statements
22,735
19,580

Fees payable to the Company's auditors in respect of:

All other services
14,920
7,325

Page 17

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

8.


Employees

Staff costs, including directors' remuneration, were as follows:


2025
2024
£
£

Wages and salaries
1,351,124
1,218,517

Social security costs
182,065
249,524

Cost of defined contribution scheme
126,511
94,178

1,659,700
1,562,219


The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
            No.







Average number of employees
20
16


9.


Directors' remuneration

2025
2024
£
£

Directors' emoluments
293,503
200,000

Company contributions to defined contribution pension schemes
21,200
20,000

314,703
220,000


During the year retirement benefits were accruing to 1 director (2024 - 1) in respect of defined contribution pension schemes.

The highest paid director received remuneration of £207,444 (2024 - £200,000).

The value of the Company's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £21,200 (2024 - £20,000).

The total accrued pension provision of the highest paid director at 28 February 2025 amounted to £NIL (2024 - £NIL).

Page 18

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

10.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
267,000
165,528


267,000
165,528


Total current tax
267,000
165,528

Deferred tax


Origination and reversal of timing differences
-
166,898

Total deferred tax
-
166,898


Tax on profit
267,000
332,426

Factors affecting tax charge for the year

The tax assessed for the year is lower than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024 - 24.49%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
1,114,626
1,316,657


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 24.49%)
278,657
322,449

Effects of:


Fixed asset differences
762
746

Movement in deferred tax not recognised
2,130
9,231

Changes in provisions leading to an increase (decrease) in the tax charge
(14,549)
-

Total tax charge for the year
267,000
332,426


Factors that may affect future tax charges

There were no factors that may affect future tax charges.

Page 19

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

11.


Tangible fixed assets







Long-term leasehold property
Motor vehicles
Fixtures and fittings
Total

£
£
£
£



Cost or valuation


At 1 March 2024
63,185
28,521
340,422
432,128


Additions
-
-
35,306
35,306


Disposals
-
-
(16,449)
(16,449)



At 28 February 2025

63,185
28,521
359,279
450,985



Depreciation


At 1 March 2024
36,399
9,507
324,187
370,093


Charge for the year on owned assets
6,836
5,704
13,212
25,752


Disposals
-
-
(16,449)
(16,449)



At 28 February 2025

43,235
15,211
320,950
379,396



Net book value



At 28 February 2025
19,950
13,310
38,329
71,589



At 29 February 2024
26,786
19,014
16,235
62,035

A loan issued by NatWest Bank has been secured by a fixed and floating charge over all the property and assets of this Company.




The net book value of land and buildings may be further analysed as follows:


28 February
29 February
2025
2024
£
£

Long leasehold
19,950
26,786

19,950
26,786


Page 20

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

12.


Debtors

28 February
29 February
2025
2024
£
£


Trade debtors
3,497,529
3,555,451

Other debtors
64,106
4,305

Prepayments and accrued income
161,551
159,998

3,723,186
3,719,754



13.


Creditors: Amounts falling due within one year

28 February
29 February
2025
2024
£
£

Trade creditors
602,143
397,280

Amounts owed to group undertakings
2,468,927
2,384,388

Corporation tax
267,041
165,532

Other taxation and social security
42,459
81,730

Other creditors
656
40

Accruals and deferred income
450,748
430,751

3,831,974
3,459,721


Amounts owed to group undertakings are unsecured, interest-free with no repayment terms.


14.


Creditors: Amounts falling due after more than one year

28 February
29 February
2025
2024
£
£

Other creditors
15,269
11,250

15,269
11,250


Page 21

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

15.


Deferred taxation






2025


£






At beginning of year
(13,287)



At end of year
(13,287)

The provision for deferred taxation is made up as follows:

28 February
29 February
2025
2024
£
£


Accelerated capital allowances
(4,139)
(4,139)

Short term timing differences
(9,148)
(9,148)

(13,287)
(13,287)


16.


Share capital

28 February
29 February
2025
2024
£
£
Allotted, called up and fully paid



10,000 (2024 - 10,000) Ordinary shares of £1.00 each
10,000
10,000



17.


Reserves

Profit and loss account

Includes all current and prior period retained profits and losses.


18.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company  to the fund and amounted to £126,511 (2024: £94,178). Contributions totalling £10,885 (2024: £10,885) were payable to the fund at the reporting date and are included in creditors.

Page 22

 
ET BROWNE (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

19.


Commitments under operating leases

At 28 February 2025 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

28 February
29 February
2025
2024
£
£


Not later than 1 year
43,997
105,593

Later than 1 year and not later than 5 years
-
43,997

43,997
149,590


20.Other financial commitments

The Company enters into forward foreign currency contracts to mitigate the exchange rate risk for certain
foreign currency trade creditors. As at 29 February 2025 there was a contract maturing within 1 month of
the Statement of Financial Position date, to buy US$1,000,000 and pay a fixed sterling amount (2024: one outstanding contracts of US$1,000,000). At year end this is valued at £796,213.


21.


Related party transactions

Where possible the Company has taken advantage of the exemption conferred by FRS 102 section 33.1A from the requirement to disclose transactions with other wholly owned group undertakings on the grounds that consolidated financial statements are prepared by the immediate parent company and are publicly available.


22.


Controlling party

The ultimate parent undertaking is ET Browne Drug Co. Inc., a company incorporated and registered in
the USA and based in New Jersey.
The largest group in which the results of ET Browne (UK) Limited are consolidated is that group headed
by ET Browne Drug Co. Inc.

 
Page 23